Copyright 2000 Journal Sentinel Inc.
Milwaukee
Journal Sentinel
August 17, 2000 Thursday FINAL EDITION
SECTION: BUSINESS; Pg. 01D
LENGTH: 69 words
HEADLINE: FDA
extends Claritin patent
BYLINE: From
Journal Sentinel wire reports
BODY:
Drug-maker Schering-Plough Corp. said the Food and
Drug Administration has approved a six-month
extension on its Claritin patent because the
company performed tests of the drug on children. Congress a few
years ago agreed to give pharmaceutical makers extended patent
time if they would test their medicines on children. Analysts say the extra six
months can mean an extra $1 billion in Claritin sales.
LOAD-DATE: August 17, 2000 
